INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study will be prospective, based on the consecutive enrollment of eligible patients at each participating institution.

NCT Number	NCT07403630
Lead Sponsor	Azienda Ospedaliero-Universitaria di Parma
Conditions	Acute Leukemia, Multiple Myeloma, Squamous Cell Carcinoma, Pleural Mesothelioma, Pancreatic Cancer, Bladder Cancer, Ovarian Cancer, Melanoma +4 more
Enrollment	300 participants
Start Date	2023-05-31
Primary Completion	2027-02 (estimated)
Study Completion	2028-02-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-17